A randomized trial of consolidation-targeted adjuvant therapy with encorafenib and cetuximab versus usual care for patients with stage II/III BRAF V600E colon cancer: Alliance for Clinical Trials in Oncology A022004
Publication
, Conference
Yaeger, R; Shi, Q; Dueck, AC; Dib, EG; Kazmi, SMA; Alese, OB; Krishnamurthi, SS; Nixon, AB; Shergill, A; O'Reilly, EM; Meyerhardt, JA
Published in: JOURNAL OF CLINICAL ONCOLOGY
2023
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2023
Volume
41
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Yaeger, R., Shi, Q., Dueck, A. C., Dib, E. G., Kazmi, S. M. A., Alese, O. B., … Meyerhardt, J. A. (2023). A randomized trial of consolidation-targeted adjuvant therapy with encorafenib and cetuximab versus usual care for patients with stage II/III BRAF V600E colon cancer: Alliance for Clinical Trials in Oncology A022004. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).
Yaeger, Rona, Qian Shi, Amylou C. Dueck, Elie G. Dib, Syed Mohammad Ali Kazmi, Olatunji B. Alese, Smitha S. Krishnamurthi, et al. “A randomized trial of consolidation-targeted adjuvant therapy with encorafenib and cetuximab versus usual care for patients with stage II/III BRAF V600E colon cancer: Alliance for Clinical Trials in Oncology A022004.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.
Yaeger R, Shi Q, Dueck AC, Dib EG, Kazmi SMA, Alese OB, et al. A randomized trial of consolidation-targeted adjuvant therapy with encorafenib and cetuximab versus usual care for patients with stage II/III BRAF V600E colon cancer: Alliance for Clinical Trials in Oncology A022004. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.
Yaeger, Rona, et al. “A randomized trial of consolidation-targeted adjuvant therapy with encorafenib and cetuximab versus usual care for patients with stage II/III BRAF V600E colon cancer: Alliance for Clinical Trials in Oncology A022004.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.
Yaeger R, Shi Q, Dueck AC, Dib EG, Kazmi SMA, Alese OB, Krishnamurthi SS, Nixon AB, Shergill A, O’Reilly EM, Meyerhardt JA. A randomized trial of consolidation-targeted adjuvant therapy with encorafenib and cetuximab versus usual care for patients with stage II/III BRAF V600E colon cancer: Alliance for Clinical Trials in Oncology A022004. JOURNAL OF CLINICAL ONCOLOGY. 2023.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2023
Volume
41
Issue
16
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences